We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance

    This comprehensive review explores vimentin as a pivotal therapeutic target in cancer treatment, with a primary focus on mitigating metastasis and...

    Aliye Tabatabaee, Behjat Nafari, ... Mina Mirian in Cancer and Metastasis Reviews
    Article 28 November 2023
  2. LAD1 promotes malignant progression by diminishing ubiquitin-dependent degradation of vimentin in gastric cancer

    Background

    Ladinin-1 (LAD1), an anchoring filament protein, has been associated with several cancer types, including cancers of the colon, lungs, and...

    Yingming Jiang, Yanchun Feng, ... Zuli Yang in Journal of Translational Medicine
    Article Open access 17 September 2023
  3. LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin

    Background

    Distant metastasis is the major cause of lung adenocarcinoma (LUAD)-associated mortality. However, molecular mechanisms involved in LUAD...

    Hao Feng, Dengfei Xu, ... Shundong Cang in Biomarker Research
    Article Open access 05 February 2024
  4. Molecular mechanism of vimentin nuclear localization associated with the migration and invasion of daughter cells derived from polyploid giant cancer cells

    Background

    Polyploid giant cancer cells (PGCCs), a specific type of cancer stem cells (CSCs), can be induced by hypoxic microenvironments, chemical...

    Linlin Fan, Minying Zheng, ... Shiwu Zhang in Journal of Translational Medicine
    Article Open access 13 October 2023
  5. CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p/PGK1 pathway and inhibiting vimentin phosphorylation

    Background

    Circular RNAs (circRNAs) have been proved to play crucial roles in the development of various cancers. However, the molecular mechanism of...

    Yongxin Zhang, Xiaofeng Wang, ... Wu Song in Journal of Translational Medicine
    Article Open access 08 March 2024
  6. The E3 ligase NEURL3 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma by promoting vimentin degradation

    Background

    Metastasis has emerged as the major reason of treatment failure and mortality in patients with nasopharyngeal carcinoma (NPC). Growing...

    Shi-Qing Zhou, Ping Feng, ... Ying-Qing Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 09 January 2024
  7. FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression

    Background

    Invasion and metastasis are the main causes of unfavourable prognosis in patients diagnosed with bladder cancer. The efficacy of...

    Wei-Min Hu, Ming Li, ... Wei-Min Yu in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 November 2023
  8. Matrix remodeling associated 7 proteins promote cutaneous wound healing through vimentin in coordinating fibroblast functions

    Wound healing depends largely on the remodeling of the extracellular matrix around and reorganization of tissue-resident cells. Matrix remodeling...

    Ying Shen, Jinling Ning, ... Yiqiang Wang in Inflammation and Regeneration
    Article Open access 16 January 2023
  9. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer

    Background

    Circulating tumor cells (CTCs) hold immense promise in guiding treatment strategies for advanced gastric cancer (GC). However, their...

    Heming Li, Yang-Zhuangzhuang Zhu, ... Mingfang Zhao in Journal of Experimental & Clinical Cancer Research
    Article Open access 30 April 2024
  10. A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity

    Background

    Osteosarcoma (OS) is one of most commonly diagnosed bone cancer. Circular RNAs (circRNAs) are a class of highly stable non-coding RNA, the...

    Ying Zhang, Zhaoyong Liu, ... Chuangzhen Chen in Journal of Experimental & Clinical Cancer Research
    Article Open access 21 February 2024
  11. A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer

    RAS oncogenes are major drivers of diverse types of cancer. However, they are largely not druggable, and therefore targeting critical downstream...

    Wuling Liu, Babu Gajendran, ... Yaacov Ben-David in Cancer Gene Therapy
    Article 27 April 2022
  12. Effects of host vimentin on Eimeria tenella sporozoite invasion

    Background

    Chicken coccidiosis is a parasitic disease caused by Eimeria of Apicomplexa, which has caused great economic loss to the poultry breeding...

    Zhan Liu, Xiangfei Geng, ... Hui Dong in Parasites & Vectors
    Article Open access 04 January 2022
  13. Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition

    Purpose

    Glioma has been demonstrated as one of the most malignant intracranial tumors and currently there is no effective treatment. Based on our...

    Yu’e Liu, Shu Zhao, ... Kaijun Zhao in Cellular Oncology
    Article 30 August 2023
  14. A Trichinella spiralis new born larvae-specific protein, Ts-NBL1, interacts with host’s cell vimentin

    The parasitic nematode Trichinella has a special relationship with its host as it has a unique intracellular location within the feeder cell which is...

    A. Wang, X. Liu, ... I. Vallée in Parasitology Research
    Article Open access 23 March 2022
  15. Generation and Release of Neurogranin, Vimentin, and MBP Proteolytic Peptides, Following Traumatic Brain Injury

    Traumatic brain injury (TBI) is a major neurological disorder without FDA-approved therapies. In this study, we have examined the concept that TBI...

    George Anis Sarkis, Nicholas Lees-Gayed, ... Kevin K. W. Wang in Molecular Neurobiology
    Article 11 November 2021
  16. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors

    Background

    Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of neoplasms with malignant behaviors that can develop from inert slow...

    Bo Zhou, Jie Xiang, ... Sheng Yan in BMC Cancer
    Article Open access 31 March 2021
  17. CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells

    Background

    CKLF like MARVEL transmembrane domain containing 6 (CMTM6) has been associated with the development in many kinds of cancers. However, the...

    Xiaoting Huang, Leyang Xiang, ... Yawei Yuan in Journal of Translational Medicine
    Article Open access 23 March 2021
  18. WD40 repeat 43 mediates cell survival, proliferation, migration and invasion via vimentin in colorectal cancer

    Background

    WD40 repeat (WDR)43 is an RNA-binding protein that belongs to the WDR domain protein family. Its biological function is largely unclear,...

    Zijian Li, Min Feng, ... Hao Wang in Cancer Cell International
    Article Open access 09 August 2021
  19. Interaction between cadherins, vimentin, and V-set and immunoglobulin domain containing 1 in gastric-type hepatocellular carcinoma

    In hepatocellular carcinomas (HCCs), the role of the cell surface protein V-set and immunoglobulin domain containing 1 (VSIG1), which is known as a...

    Simona Gurzu, Haruhiko Sugimura, ... Ioan Jung in Histochemistry and Cell Biology
    Article 25 June 2021
  20. MicroRNA-146a suppresses tumor malignancy via targeting vimentin in esophageal squamous cell carcinoma cells with lower fibronectin membrane assembly

    Background

    Esophageal squamous cell carcinoma (ESCC) is widely prevalent in Taiwan, and high metastatic spread of ESCC leads to poor survival rate....

    Hong-Yi Chang, Chi-Hua Lee, ... Hung-Chi Cheng in Journal of Biomedical Science
    Article Open access 28 November 2020
Did you find what you were looking for? Share feedback.